Free Trial
NYSE:STE

STERIS (STE) Stock Price, News & Analysis

STERIS logo
$231.49 -1.25 (-0.54%)
Closing price 03/10/2025 03:59 PM Eastern
Extended Trading
$232.39 +0.90 (+0.39%)
As of 03/10/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About STERIS Stock (NYSE:STE)

Key Stats

Today's Range
$230.21
$236.83
50-Day Range
$202.46
$233.02
52-Week Range
$197.82
$248.24
Volume
668,637 shs
Average Volume
522,987 shs
Market Capitalization
$22.74 billion
P/E Ratio
49.15
Dividend Yield
0.98%
Price Target
$258.75
Consensus Rating
Moderate Buy

Company Overview

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Remove Ads

STERIS Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
95th Percentile Overall Score

STE MarketRank™: 

STERIS scored higher than 95% of companies evaluated by MarketBeat, and ranked 38th out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    STERIS has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    STERIS has only been the subject of 3 research reports in the past 90 days.

  • Read more about STERIS's stock forecast and price target.
  • Earnings Growth

    Earnings for STERIS are expected to grow by 9.36% in the coming year, from $9.08 to $9.93 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of STERIS is 49.15, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.49.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of STERIS is 49.15, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 24.92.

  • Price to Book Value per Share Ratio

    STERIS has a P/B Ratio of 3.54. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about STERIS's valuation and earnings.
  • Percentage of Shares Shorted

    0.95% of the float of STERIS has been sold short.
  • Short Interest Ratio / Days to Cover

    STERIS has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in STERIS has recently decreased by 5.75%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    STERIS pays a meaningful dividend of 1.01%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    STERIS has been increasing its dividend for 20 years.

  • Dividend Coverage

    The dividend payout ratio of STERIS is 48.41%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, STERIS will have a dividend payout ratio of 22.96% next year. This indicates that STERIS will be able to sustain or increase its dividend.

  • Read more about STERIS's dividend.
  • Percentage of Shares Shorted

    0.95% of the float of STERIS has been sold short.
  • Short Interest Ratio / Days to Cover

    STERIS has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in STERIS has recently decreased by 5.75%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    STERIS has a news sentiment score of 1.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 15 news articles for STERIS this week, compared to 8 articles on an average week.
  • Search Interest

    1 people have searched for STE on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 2 people have added STERIS to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, STERIS insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.14% of the stock of STERIS is held by insiders.

  • Percentage Held by Institutions

    94.69% of the stock of STERIS is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about STERIS's insider trading history.
Receive STE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STERIS and its competitors with MarketBeat's FREE daily newsletter.

STE Stock News Headlines

Zacks Research Issues Negative Forecast for STERIS Earnings
Trump doesn’t give a damn
Porter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met with one of Trump’s longest-serving advisors. We helped put together a plan to help investors capitalize on Trump’s election. And we found out these 10 stocks are the most likely to boom…
1 Healthcare Stock Primed for Growth and 2 to Avoid
See More Headlines

STE Stock Analysis - Frequently Asked Questions

STERIS's stock was trading at $205.56 at the start of the year. Since then, STE stock has increased by 12.6% and is now trading at $231.4860.
View the best growth stocks for 2025 here
.

STERIS plc (NYSE:STE) posted its quarterly earnings results on Wednesday, February, 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by $0.01. STERIS had a net margin of 8.66% and a trailing twelve-month return on equity of 13.91%.
Read the conference call transcript
.

STERIS's top institutional shareholders include Vanguard Group Inc. (12.07%), Massachusetts Financial Services Co. MA (5.05%), WCM Investment Management LLC (4.56%) and Select Equity Group L.P. (2.65%). Insiders that own company stock include Michael J Tokich, John Adam Zangerle, Mohsen Sohi, Cary L Majors, Renato Tamaro, Jacqueline B Kosecoff and Karen L Burton.
View institutional ownership trends
.

Shares of STE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that STERIS investors own include Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), JPMorgan Chase & Co. (JPM), Visa (V), Home Depot (HD) and Advanced Micro Devices (AMD).

Company Calendar

Ex-Dividend for 12/19 Dividend
11/19/2024
Dividend Payable
12/19/2024
Last Earnings
2/05/2025
Ex-Dividend for 3/21 Dividend
2/20/2025
Today
3/11/2025
Dividend Payable
3/21/2025
Fiscal Year End
3/31/2025
Next Earnings (Estimated)
5/14/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Health Care Equipment
Current Symbol
NYSE:STE
Employees
18,179
Year Founded
1987

Price Target and Rating

Average Stock Price Target
$258.75
High Stock Price Target
$265.00
Low Stock Price Target
$240.00
Potential Upside/Downside
+11.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Trailing P/E Ratio
49.15
Forward P/E Ratio
25.49
P/E Growth
N/A
Net Income
$378.24 million
Pretax Margin
14.62%

Debt

Sales & Book Value

Annual Sales
$5.40 billion
Cash Flow
$14.72 per share
Price / Cash Flow
15.73
Book Value
$65.43 per share
Price / Book
3.54

Miscellaneous

Free Float
97,131,000
Market Cap
$22.74 billion
Optionable
Optionable
Beta
0.92

Social Links

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (NYSE:STE) was last updated on 3/11/2025 by MarketBeat.com Staff
From Our Partners